Latest Insider Transactions at Integrated Biopharma Inc (INBP)
This section provides a real-time view of insider transactions for Integrated Biopharma Inc (INBP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTEGRATED BIOPHARMA INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTEGRATED BIOPHARMA INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 25
2024
|
Christina Kay Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,555
+4.01%
|
$0
$0.09 P/Share
|
|
Nov 25
2024
|
Sheppard Riva Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,555
+4.01%
|
$0
$0.09 P/Share
|
|
Nov 25
2024
|
Dina Masi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+23.45%
|
$0
$0.09 P/Share
|
|
Sep 20
2023
|
Sheppard Riva Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+3.78%
|
$0
$0.09 P/Share
|
|
Sep 20
2023
|
Christina Kay Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+3.78%
|
$0
$0.09 P/Share
|
|
Sep 20
2023
|
Dina Masi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+25.36%
|
$0
$0.09 P/Share
|
|
May 30
2023
|
Christina Kay Co-Chief Executive Officer |
BUY
Bona fide gift
|
Direct |
50,000
+2.69%
|
$0
$0.34 P/Share
|
|
May 30
2023
|
Sheppard Riva Co-Chief Executive Officer |
BUY
Bona fide gift
|
Direct |
50,000
+2.69%
|
$0
$0.34 P/Share
|
|
May 25
2023
|
Sheppard Riva Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
3,410,512
+49.89%
|
$0
$0.4 P/Share
|
|
May 25
2023
|
Christina Kay Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
3,410,512
+50.0%
|
$0
$0.4 P/Share
|
|
May 06
2022
|
E Gerald Kay Executive Chairman & President |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+1.84%
|
$0
$0.23 P/Share
|